Artificial Intelligence in Medical Writing Market Outlook:
Artificial Intelligence in Medical Writing Market size was over USD 878.08 million in 2025 and is anticipated to cross USD 2.78 billion by 2035, witnessing more than 12.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of artificial intelligence in medical writing is assessed at USD 974.49 million.
The increasing complexity of healthcare data, the need for faster drug approvals, and the rise in clinical trials are key factors fueling the adoption of AI in medical writing. Technologies, such as NLP, and machine learning are helping reduce human error, improve accuracy, and streamline workflows, particularly in the pharmaceutical and healthcare sectors.
Moreover, regulatory authorities in various regions are starting to accept AI-generated documents, further accelerating the AI in medical writing market growth. In the upcoming years, AI is expected to advance further in automating not just routine writing tasks but also predictive analytics in clinical research. In June 2023, Amazon Web Services, Inc. announced a new HIPAA-eligible service, AWS HealthScribe with generative AI capabilities for natural language processing solutions. Such activities are projected to further boost the artificial intelligence (AI) in medical writing market expansion globally.
